Home›Companies›Healthcare›Sword Bio

Sword Bio, Inc.

Updated Oct 29, 2026·Latest SEC filing Jun 26, 2023·Suggest an edit

About Sword Bio

Sword Bio is a private company based in Carmel, Indiana. It has reported $3,437,405 raised in five offerings on Form D since October 2009. Its chief executive is David Dingott.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 15, 2023Jun 26, 2023$50,000of $1.5M target1$50,000Equity, OptionsRule 506(b)Form D ↗
Mar 12, 2018Mar 27, 2018$1,526,603of $2.5M target2$763KEquity, OptionsRule 506(b)Form D ↗
May 12, 2015May 13, 2015$150,000of $1.5M target1$150KDebt, Securities on exerciseRule 506(c)Form D ↗
Aug 9, 2011Dec 28, 2012$1,274,971of $3.0M target16$79,686Debt, Options06Form D ↗
Sep 30, 2009Oct 13, 2009$435,831of $1.0M target7$62,262Debt, Options06Form D ↗
Total, five offerings$3,437,405

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sword Bio's Form D filed Jun 26, 2023.

DD
David Dingott
President and Chief Executive Officer, director
EG
Edward Grogg
Director
GP
Gail Page
Director
MS
Mel Schatz
Director

Earlier filings also listed Michael Shepard (director, last listed May 2015), Joseph Falkenstein (director, last listed Dec 2012) and Sidney Braginsky (director, last listed Oct 2009).

Sources

  1. SECSword Bio, Inc. filing history